IL-8 enhancement of amyloid-beta (Aβ1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia

被引:78
作者
Franciosi, S
Choi, HB
Kim, SU
McLarnon, JG
机构
[1] Univ British Columbia, Dept Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Fac Med, Div Neurol, Dept Med, Vancouver, BC V6T 2B5, Canada
[3] Ajou Univ, Brain Dis Res Ctr, Suwon, South Korea
关键词
human microglia; amyloid beta; interleukin-8; brain inflammation; cytokine; cyclooxygenase-2;
D O I
10.1016/j.jneuroim.2004.10.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effects of the chemokine IL-8 on amyloid beta peptide (Abeta(1-42))-induced responses in cultured human microglia were investigated using RT-PCR, ELISA and immunocytochemistry. Abeta(1-42) (5 muM) applied for 8 h induced the expression and increased the production of the pro-inflammatory cytokines IL-6, IL-1beta, TNF-alpha, the inducible enzyme COX-2 and chemokine IL-8. Microglial treatment with IL-8 added (at 100 ng/mL) with Abeta(1-42) led to enhancement in both expression and production of all of these pro-inflammatory factors compared with peptide alone. Stimulation with IL-8 itself was effective in increasing microglial expression of pro-inflammatory cytokines, IL-8 and COX-2, however, had no effect on protein levels of all these factors. The expression of the anti-inflammatory cytokines IL-10 and TGFbeta(1) remained unchanged from basal levels with stimulation using either Abeta(1-42), IL-8 or the peptide together with IL-8. The actions of IL-8 to potentiate Abeta(l-42)-induced inflammatory mediators may have particular relevance to Alzheimer disease brain which exhibits elevated levels of the chemokine. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:66 / 74
页数:9
相关论文
共 43 条
  • [1] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [2] BADOLATO R, 1995, J IMMUNOL, V155, P4004
  • [3] INFLAMMATORY CYTOKINES WITHIN THE CENTRAL-NERVOUS-SYSTEM - SOURCES, FUNCTION, AND MECHANISM OF ACTION
    BENVENISTE, EN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01): : C1 - C16
  • [4] Differential activation of subtype purinergic receptors modulates Ca2+ mobilization and COX-2 in human microglia
    Choi, HB
    Hong, SH
    Ryu, JK
    Kim, SU
    McLarnon, JG
    [J]. GLIA, 2003, 43 (02) : 95 - 103
  • [5] Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-α and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195
    Choi, HB
    Khoo, C
    Ryu, JK
    van Breemen, E
    Kim, SU
    McLarnon, JG
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 83 (03) : 546 - 555
  • [6] Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO
  • [7] 2-J
  • [8] THE AMYLOID BETA-PROTEIN OF ALZHEIMERS-DISEASE IS CHEMOTACTIC FOR MONONUCLEAR PHAGOCYTES
    DAVIS, JB
    MCMURRAY, HF
    SCHUBERT, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (02) : 1096 - 1100
  • [9] Ehrlich LC, 1998, J IMMUNOL, V160, P1944
  • [10] Frautschy SA, 1998, AM J PATHOL, V152, P307